FORT LAUDERDALE, FL–June 6, 2019–ImmunSYS, Inc. announced today that Chairman & CEO Eamonn Hobbs presented on June 3rd at the 2019 BIO International Conference, held at the Pennsylvania Convention Center in Philadelphia. BIO 2019 featured over 17,000 attendees, more than 8400 companies, over 250 company presentations, and 126 educational sessions.
Prostate cancer treatment, in particular, can lead to ED. The prostate gland is situated near nerves that are crucial for erections. Thus, surgeries that involve removing the prostate can potentially damage these nerves, leading to ED. Both radical prostatectomy (complete removal of the prostate gland) and radiation therapy for prostate cancer can cause ED.BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
For more information on the convention, please visit https://convention.bio.org/2019bythenumbers/. In addition, Mr. Hobbs’ presentation from the meeting can be viewed below.
